T2D, kidney protection, peripheral arterial disease & SGLT2 inhibitors: act early
Nephroprotective measures in patients with type 2 diabetes were reviewed by Prof. Ariane SULTAN during the annual meeting of the Société Francophone du Diabète (SFD),…

This is custom heading element
For the advancement of diabetes research
‼️ DISCOVER THE 2025 WINNERS ‼️
The Scientific Council of the Fondation Francophone pour la Recherche sur le Diabète – FFRD – has made its decision! 2025 marks its 13th call for projects with nearly 40 Francophone applicants…

🚦 Since 2013, it means a total of:
🙏 The FFRD thanks its faithful partners and donors and is proud to dedicate more than 80% of its expenditures to diabetes research in Francophonie !
📆 Openning of the next FFRD call for projects in February 2026…
🎯 Promoting and supporting diabetes research, its mechanisms, prevention, managemnet, comorbidities and complications…
For the advancement of diabetes research and TO REDUCE THE BURDEN OF THE DISEASE 🩸
Nephroprotective measures in patients with type 2 diabetes were reviewed by Prof. Ariane SULTAN during the annual meeting of the Société Francophone du Diabète (SFD),…
Finalization of the calendar for the Board of Directors
Overview of 2025 and projections for 2026
Validation of the 2026 calendar

The Francophone Foundation for Diabetes Research (FFRD) serves as the “armed wing” of the Francophone Diabetes Society (SFD) with the aim of promoting excellence in diabetes research, a common disease whose prevalence continues to rise. High-level and large-scale research is truly essential to get further insight into the mechanisms involved in the development of diabetes and its complications, as well as to improve their treatment and prevention.
The FFRD supports clinical, basic, and translational research.
The supported basic research projects address major themes of type 1 and type 2 diabetes
covering subjects such as pancreatic beta cells, insulin resistance, and intestinal microbiota.
The clinical research projects, on the other hand, address the themes of type 1 and type 2 diabetes, as well as gestational diabetes
and often involve large multicenter cohort studies.
Since 2013, the Foundation has been:

